What Fractional Leadership Looks Like in Practice
Fractional C-level leadership is not consulting. It is embedded executive presence - typically 2-3 days per week - with real accountability, team ownership, and board-level authority. Dr. Kurr works as part of the leadership team, not as an external advisor looking in. This means attending board meetings, owning strategic initiatives, managing direct reports, and driving execution alongside the CEO and founding team. The model works especially well for scale-ups moving from founder-led to professionally managed, portfolio companies under investor oversight, and organizations navigating executive transitions.
Roles Dr. Kurr Fills
The most common fractional mandates are Chief Commercial Officer (CCO) - leading commercial strategy, go-to-market operations, partnerships, and revenue growth; Chief Transformation Officer (CTO) - driving end-to-end organizational transformation, operating model redesign, and digital enablement; and Chief Operating Officer (COO) - overseeing operational excellence, service delivery, and cross-functional process optimization. Dr. Kurr also serves as interim executive during leadership transitions and as a C-suite sparring partner for CEOs and founders navigating complex strategic decisions.
Why This Works for Pharma & Life Sciences
Regulated industries require executives who understand compliance, market access, medical affairs, and the unique dynamics of pharma commercialization. A fractional leader from outside the industry creates risk. Dr. Kurr brings 20+ years of direct pharma experience - at Boehringer Ingelheim, Novartis, and now across biotech and MedTech - ensuring that strategic decisions are grounded in deep domain knowledge. At Lemna Bio, he leads commercial strategy and partnership development for a computational drug design company. At THENA Capital, he provides strategic counsel to a specialist MedTech investor evaluating early-stage digital health and device companies.
The Business Case
A full-time C-level executive in pharma commands a total cost of €400-600K+ annually. A fractional mandate delivers the same caliber of leadership at 30-50% of that cost - with the flexibility to scale engagement up or down as the business evolves. For investors, this means deploying experienced operating leadership across portfolio companies without the overhead. For founders, it means accessing executive experience that would otherwise be out of reach.